vidarabine phosphate has been researched along with B-Cell Lymphoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bashey, A; Baxter-Lowe, LA; Farag, S; Isola, L; Johnson, J; Kelly, M; Linker, C; McCarty, J; Owzar, K; Shea, T; Westervelt, P | 1 |
| Zinzani, PL | 1 |
| Hotta, T; Minami, H; Morishima, Y; Ogawa, Y; Ogura, M; Sasaki, Y; Seriu, T; Tobinai, K; Watanabe, T | 1 |
| Hayashi, M; Hotta, T; Ishizawa, K; Matsuno, Y; Matsusako, M; Minami, H; Mori, S; Morishima, Y; Nakamura, S; Nawano, S; Ogawa, Y; Ogura, M; Ohashi, Y; Seriu, T; Taniwaki, M; Terauchi, T; Tobinai, K; Utsunomiya, A; Watanabe, T | 1 |
1 review(s) available for vidarabine phosphate and B-Cell Lymphoma
| Article | Year |
|---|---|
Traditional treatment approaches in B-cell non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Humans; Lymphoma, B-Cell; Neoplasm Staging; Risk Assessment; Treatment Outcome; Vidarabine Phosphate | 2003 |
3 trial(s) available for vidarabine phosphate and B-Cell Lymphoma
| Article | Year |
|---|---|
Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901.
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Middle Aged; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine Phosphate | 2011 |
Phase I and pharmacokinetic study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Vidarabine Phosphate | 2006 |
Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Recurrence; Vidarabine Phosphate | 2006 |